A Pilot Study of MPDL3280A (PD-L1) Antibody Therapy and Hypofractionated Image-guided Radiotherapy (HIGRT) in Patients With Metastatic Non-Small Cell Lung Cancer
Active, no longer recruiting
Phase of Trial: Phase 0
Latest Information Update: 22 Mar 2017
At a glance
- Drugs Atezolizumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 16 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 21 Oct 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov record.